Storys zum Thema Impfung

News Direct

Q-VANT and In vitro Plant-tech Sign Agreement for the Development and Supply of Quillaja saponaria Plant Cell Culture Biomass

BOSTON, MA (ots) - --News Direct-- Q-VANT Biosciences, the first company to achieve a 100% sustainable way to meet the growing global vaccine market demand for Quillaja saponin-based adjuvants, today announced that it has signed an agreement with In vitro Plant-tech AB, a Swedish plant cell cultivation company whose ...

News Direct

ALDER HEY AND NEEDLESMART PARTNERSHIP AIMS TO REDUCE 100,000 NEEDLESTICK INJURIES TO NHS HEALTHCARE WORKERS

Technische Universität München

A medication against SARS-CoV-2 – new strategy also promises protection against future SARS-CoV-2 variants

TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37076 High resolution images: https://mediatum.ub.tum.de/1637268 NEWS RELEASE A medication against ...

R-Biopharm AG

2

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

MECOTEC GmbH

2

German MECOTEC Group delivers 8 containers for deep-freeze storage of Covid-Vaccines

eleva GmbH

Eleva Enters Clinical Development of Difficult-To-Express High-Potential Proteins

Freiburg (ots) - Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, as well as in collaboration with pharmaceutical partners. Its moss-based platform is ideally suited to produce difficult-to-express but therapeutically promising drug candidates. Its recently expanded production ...

MAHLE International GmbH

6

Press Release MAHLE Covid-19 worldwide vaccination initiatives

Technische Universität München

New approach identifies T cells in Covid-19 patients

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36882/ NEWS RELEASE New approach identifies T cells in Covid-19 patients Immune cell profile reveals appearance, number and activity level against SARS-CoV-2 T cells play a decisive role in fighting the ...

Technische Universität München

The virus trap: hollow nano-objects made of DNA could trap viruses and render them harmless

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36810/ High resolution images: https://mediatum.ub.tum.de/1616943 NEWS RELEASE The virus trap Hollow ...

Technische Universität München

Versatile, fast and reliable: new automated microarray rapid test detects SARS-CoV-2 antibodies

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36762/ High resolution images: https://mediatum.ub.tum.de/1615381 NEWS RELEASE Versatile, fast and reliable SARS-CoV-2 antibody assay Automated microarray ...

nal von minden GmbH

Did my vaccine work? New rapid test for the determination of vaccination success

DG-Nika AG

First pocket inhaler for Covid-19 and other viral mutations

Buochs (ots) - DG-Nika AG – a new approach to therapy & proactive protection from the pandemic The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the ...

Hellmann Worldwide Logistics

Hellmann provides Germany-wide distribution of COVID-19 vaccines for the government

nal von minden GmbH

nal von minden plans to produce 80 million rapid corona tests per month

MECOTEC GmbH

2

German MECOTEC Group launches one-stop-solution for deep-freeze, transport, storage and distribution for COVID-19-Vaccines with its first Mobile Hybrid Container

Swiss Rockets AG

Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine

Technische Universität München

Immune response: memory T cells are formed earlier than previously thought

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36297/ NEWS RELEASE How the immune system remembers viruses Immune response: memory T cells are formed earlier than previously thought For a person to ...

nal von minden GmbH

New: Combined rapid test for Covid-19 and influenza

IgNova GmbH

IgNova files patent application on antibody against COVID-19

Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...

Cilian AG

New in-vivo study confirms that ciliate vaccine protects against flu